- Main
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.
- Amato, Anthony A;
- Hanna, Michael G;
- Machado, Pedro M;
- Badrising, Umesh A;
- Chinoy, Hector;
- Benveniste, Olivier;
- Karanam, Ananda Krishna;
- Wu, Min;
- Tankó, László B;
- Schubert-Tennigkeit, Agnes Annette;
- Papanicolaou, Dimitris A;
- Lloyd, Thomas E;
- Needham, Merrilee;
- Liang, Christina;
- Reardon, Katrina A;
- de Visser, Marianne;
- Ascherman, Dana P;
- Barohn, Richard J;
- Dimachkie, Mazen M;
- Miller, James AL;
- Kissel, John T;
- Oskarsson, Björn;
- Joyce, Nanette C;
- Van den Bergh, Peter;
- Baets, Jonathan;
- De Bleecker, Jan L;
- Karam, Chafic;
- David, William S;
- Mirabella, Massimiliano;
- Nations, Sharon P;
- Jung, Hans H;
- Pegoraro, Elena;
- Maggi, Lorenzo;
- Rodolico, Carmelo;
- Filosto, Massimiliano;
- Shaibani, Aziz I;
- Sivakumar, Kumaraswamy;
- Goyal, Namita A;
- Mori-Yoshimura, Madoka;
- Yamashita, Satoshi;
- Suzuki, Naoki;
- Aoki, Masashi;
- Katsuno, Masahisa;
- Morihata, Hirokazu;
- Murata, Kenya;
- Nodera, Hiroyuki;
- Nishino, Ichizo;
- Romano, Carla D;
- Williams, Valerie SL;
- Vissing, John;
- Zhang Auberson, Lixin;
- Walters, Susan;
- Hathorn, Dave;
- Salman, Sam;
- Burk, Melanie;
- Chen, Ruby;
- Jenkins, Mary;
- Sue, Carolyn;
- Mathers, Susan;
- Krasniqi, Ruth;
- Mottram, Lisa;
- Fitzgerald, Katie;
- Howe, James;
- Files, Hanne;
- Chen, Ruby;
- Wagemaekers, Linda;
- De Jonghe, Peter;
- Mahieu, Delphine;
- Heremans, Tom;
- de Koning, Kathy;
- De Mey, Katrien;
- Cardoen, Stefanie;
- Miclotte, Chantal;
- Bioul, Marie-Odile;
- Autzen, Anne Mette;
- Dahlqvist, Julia Rebecka;
- Jorsal, Martin;
- Witting, Nanna;
- Pedersen, Jane;
- Knak, Kirsten;
- Andersen, Linda;
- Tanderup Joergensen, Maj-Brit;
- Hogrel, Jean yves;
- Gilardin, Laurent;
- Ollivier, Gwenn;
- Champtiaux, Nicolas;
- Decostre, Valérie;
- Rigolet, Aude;
- Lilien, Charlotte;
- Allenbach, Yves;
- Simon, Anne;
- Bachasson, Damien;
- De Fino, Chiara;
- Lucchini, Matteo;
- Bianco, Assunta;
- Losavio, Francesco;
- Bello, Luca;
- Martinelli, Ilaria;
- Semplicini, Claudio;
- Gaiani, Alessandra;
- Ballabio, Marta;
- Gaiani, Alessandra;
- Bussolino, Chiara;
- Campanella, Angela;
- Pasanisi, Maria;
- Portaro, Simona;
- Cavallaro, Filippo;
- Simon, Anne;
- Bachasson, Damien;
- De Fino, Chiara;
- Lucchini, Matteo;
- Bianco, Assunta;
- Losavio, Francesco;
- Bello, Luca;
- Martinelli, Ilaria;
- Semplicini, Claudio;
- Gaiani, Alessandra;
- Ballabio, Marta;
- Gaiani, Alessandra;
- Bussolino, Chiara;
- Campanella, Angela;
- Pasanisi, Maria;
- Portaro, Simona;
- Cavallaro, Filippo;
- Biasini, Fiammetta;
- Parisi, Daniela;
- Todeschini, Alice;
- Volonghi, Irene;
- Rota, Silvia;
- Damioli, Simona;
- Ono, Hiroya;
- Shijo, Tomomi;
- Izumi, Rumiko;
- Akiyama, Tetsuya;
- Ikeda, Kensuke;
- Wakasugi, Noritaka;
- Kawazoe, Tomoya;
- Tasaki, Asami;
- Murata, Miho;
- Saotome, Takako;
- Aihara, Yuki;
- Ariake, Yosuke;
- Fujiwara, Mai;
- Takeuchi, Mizuki;
- Tateishi, Takayuki;
- Tsujikawa, Koyo;
- Endo, Kuniyuki;
- Ogura, Aya;
- Noda, Seiya;
- Nakanishi, Hirotaka;
- Ikumi, Kazuhiro;
- Ito, Daisuke;
- Hattori, Makoto;
- Takeda, Kiyoaki;
- Yoshimura, Kenji;
- Kanki, Rie;
- Taniguchi, Michiyo;
- Nakano, Satoshi;
- Kanki, Rie;
- Yoshimura, Kenji;
- Takeda, Kiyoaki;
- Hayashi, Maiko;
- Wada, Minako;
- Taniguchi, Michiyo;
- Murakami, Ayumi;
- Murata, Kenya;
- Hironishi, Masaya;
- Hiwatani, Yasuhiro;
- Yasui, Masaaki;
- Izawa, Masae;
- Koh, Jinsoo;
- Hosokawa, Maki;
- Mori, Megumi;
- Nakayama, Yoshiaki;
- Yorozu, Shoko;
- Taruya, Junko;
- Ohno, Chigusa;
- Kawasaki, Shinji;
- Nishimura, Yukihide;
- Miyazaki, Yoshimichi;
- Matsui, Naoko;
- Yamazaki, Hiroki;
- Furumoto, Taiki;
- Masuda, Teruaki;
- Yonemochi, Yasuhiro;
- Tawara, Nozomu;
- Takamatsu, Koutarou;
- van Heur-Neuman, Marjolein;
- Koeks, Zaida;
- Straathof, Chiara;
- Mosselman, Martha;
- Krom, Yvonne;
- Lipka, Alexander;
- Strijbos, E;
- Niks, E;
- Verschuuren, J;
- Eftimov, Filip;
- Clerx, Guido;
- Gibson, Tamar;
- van der Kooi, Anneke;
- Christen, Barbara;
- Petersen, Jens;
- Cataldo, Evelyne;
- Nguyen-Kim, Dan;
- Andreisek, Gustav;
- Frese, Sebastian;
- Mihaylova, Violeta;
- Diana, kallies;
- Mueller, Sandro;
- Boehler, Andrea;
- Hennelly, Laura;
- Budnik, Natalia;
- Xing, Liying;
- Guile, Kerry;
- Chabo, Cathleen;
- Hunter, Heather;
- Carman, Dorothy;
- Pilkington, Helen;
- Price, Maria;
- Brown, Philip;
- McNichol, Ann;
- Durcan, Rory;
- Green, Angela;
- Smith, Fairbarin;
- Walker, Kathryn;
- O'Dowd, Sean;
- Wibin, Louise;
- Mcnichol, Ann;
- McDonald, Claire;
- Chadwick, Julie;
- Raza, SM Ammar;
- Raman, Mahrajan;
- Lambe, Catherine;
- Prais, Hilary;
- Harwood, Nikki;
- Rita, Ammar;
- Raman, Maharajan;
- Harwood, Nikki;
- Lambe, Catherine;
- Vassallo, Diane;
- Lilleker, James;
- Caldwell, Shirley;
- Khan, Armgan;
- Keichian, Andres;
- Alzubaidi, Mohanad;
- Villegas, Yeni;
- Tupue, Allen;
- Habeeb, Ali;
- Bhagi, Gaurika;
- Beck, Kristen;
- Burbar, Tatiana;
- Mauldin, Leigh;
- Rasheed, Zina;
- Cline, Nancy;
- Harris, Piper;
- Osgood, Kristy;
- Sivakumar, Preethi Nimalka;
- Bootka, Kulette;
- Narayanan, Vinodh;
- Spector, Sidney;
- Kline, Christine;
- Gonzalez, Mark;
- Pasnoor, Mamatha;
- Statland, Jeffrey;
- Walsh, Maureen;
- Glen, Melenie;
- Currence, Melissa;
- Herbelin, Laura;
- Dimachkie, Mazen;
- Rico, Gabrielle;
- McCalley, Ayla;
- Amato, Katie;
- Shah, Nikita;
- Zinchuk, Kevin;
- Roe, Kristen;
- Rydingsward, Jessica;
- Salajegheh, Mohammed;
- Chused, Samantha;
- Mirch, Katherine;
- Cochrane, Thomas;
- Flynn, Patricia;
- Guidon, Amanda;
- Cornacchio, Sarah;
- Gonterman, Fernando;
- Ellrodt, Amy;
- Bissell, Magen;
- Watkins, Tyler;
- Robichaud, Ashley;
- Bwala, Grace;
- Nicholson, Katharine;
- Andres, Patricia;
- Arnold, Melissa;
- Trivedi, Jaya;
- Phillips, Lauren;
- Chelnick, Sharon;
- Quick, Adam;
- Agriesti, Julie;
- Muharrem, Filiz;
- Freimer, Miriam;
- Iyadurai, Stanley;
- King, Wendy;
- Stino, Amro;
- Mezache, Louise;
- Matthew, Veena;
- Martin, Veronica;
- Mozaffar, Tahseen;
- Cash, Tiyonnoh;
- Hufnagel, Trisha;
- Peyronnard, Caroline;
- Nayyar, Sonia;
- Aubourg, Bethly;
- Pignac-Kobinger, Judith;
- Almahuer, Alexandra;
- Milian, Alexyz;
- Miller, Chelsea;
- Greidinger, Eric;
- Harlow, Lisa;
- Aubourg, Bethly;
- Pignac-Kobinger, Judith;
- Riley, Kristen;
- Clawson, Lora;
- Uchil, Alpa;
- Christopher-Stine, Lisa;
- Slusher, Rachel;
- Kumble, Sowmya;
- Riley, Kristen;
- Khoury, Julie;
- Kaur, Harpreet;
- Khoury, Julie;
- Dimitrova, Diana;
- Bernard, Brooke;
- Anthonisen, Colleen;
- Sundby, Natasha;
- Goude, Erica;
- Aguilar, Candace;
- Davis, Carly;
- Toor, Jaijeet;
- Sandhu, Randev;
- Johnson, Linda;
- Cregan, Michelle;
- Yang, Sasa;
- Macabales, Sarah;
- Owens, Corey;
- Mcdonald, Criag;
- Ha, James;
- Williams, Lisa;
- Nicorici, Alina;
- Henricson, Eric;
- Bernard, Brooke
Published Web Location
https://doi.org/10.1212/wnl.0000000000011626Abstract
OBJECTIVE: To assess long-term (2 years) effects of bimagrumab in participants with sporadic inclusion body myositis (sIBM). METHODS: Participants (aged 36-85 years) who completed the core study (RESILIENT [Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients]) were invited to join an extension study. Individuals continued on the same treatment as in the core study (10 mg/kg, 3 mg/kg, 1 mg/kg bimagrumab or matching placebo administered as IV infusions every 4 weeks). The co-primary outcome measures were 6-minute walk distance (6MWD) and safety. RESULTS: Between November 2015 and February 2017, 211 participants entered double-blind placebo-controlled period of the extension study. Mean change in 6MWD from baseline was highly variable across treatment groups, but indicated progressive deterioration from weeks 24-104 in all treatment groups. Overall, 91.0% (n = 142) of participants in the pooled bimagrumab group and 89.1% (n = 49) in the placebo group had ≥1 treatment-emergent adverse event (AE). Falls were slightly higher in the bimagrumab 3 mg/kg group vs 10 mg/kg, 1 mg/kg, and placebo groups (69.2% [n = 36 of 52] vs 56.6% [n = 30 of 53], 58.8% [n = 30 of 51], and 61.8% [n = 34 of 55], respectively). The most frequently reported AEs in the pooled bimagrumab group were diarrhea 14.7% (n = 23), involuntary muscle contractions 9.6% (n = 15), and rash 5.1% (n = 8). Incidence of serious AEs was comparable between the pooled bimagrumab and the placebo group (18.6% [n = 29] vs 14.5% [n = 8], respectively). CONCLUSION: Extended treatment with bimagrumab up to 2 years produced a good safety profile and was well-tolerated, but did not provide clinical benefits in terms of improvement in mobility. The extension study was terminated early due to core study not meeting its primary endpoint. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov identifier NCT02573467. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for patients with sIBM, long-term treatment with bimagrumab was safe, well-tolerated, and did not provide meaningful functional benefit. The study is rated Class IV because of the open-label design of extension treatment period 2.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.